Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 600

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 600
---
 for the benefit of each Public Share that was not redeemed in connection with the Company’s extension from May 8, 2024 to November 8, 2024 (the “May 2024 Extension”). The Sponsor agreed to pay $37,500 per month until the completion of an initial Business Combination, commencing on May 8, 2024 and continuing through November 8, 2024. The May 2024 Promissory Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which we consummate our Business Combination and (ii) the date that our winding up is effective. As of September 30, 2024 and December 31, 2023, the Company had $187,500 and $0, respectively, outstanding under the May 2024 Promissory Note, which is included in the Promissory Note payable — related party account on the accompanying condensed balance sheets. On November11, 2024, the Company issued an unsecured promissory note (the “November 2024 Note”) in the aggregate principal amount of up to $259,588 to the Sponsor, which will be deposited into the Trust Account for the benefit of each Public Share that was not redeemed in connection with the November 2024 Extension. The Sponsor agreed to pay $43,264.60 per month until the completion of an initial Business Combination, commencing on November8, 2024 and continuing through May8, 2025. The November 2024 Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which we consummate our Business Combination and (ii) the date that our winding up is effective. As of January6, 2025, the Company had deposited $86,670 (including $140.80 of applicable interest) into the Company’s Trust Account. These conditions, involving liquidity concerns and mandatory liquidation, raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the accompanying unaudited condensed financial statements are issued. There is no assurance that the Company’s plan to consummate a Business Combination will be successful or successful within the Combination Period. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Sunorange Investment On April 27, 2023, the Company entered into an agreement (the “Investment Agreement”) with